Loading…

WM agreed to acquire a controlling interest in Avangard Innovative's U.S. business, which will operate as Natura PCR, an independent company expected to scale recycling capacity to produce 400 million pounds per year of post-consumer resin in five years.
“WM's controlling interest in Natura PCR positions us to grow and scale rapidly in the emerging PCR space.”mediaroom.wm.com
Summarized from public sources; check the original articles before acting on it.